Silent myocardial ischemia and cardiovascular responses to anger provocation in older adults

被引:0
作者
Jessica P. Brown
Leslie I. Katzel
Serina A. Neumann
Shari R. Waldstein
Karl J. Maier
机构
[1] University of Maryland School of Medicine,Department of Epidemiology and Preventive Medicine
[2] University of Maryland School of Medicine & Geriatric Research Education and Clinical Center,Department of Medicine, Division of Gerontology
[3] Baltimore Veterans Affairs Medical Center,Department of Psychology
[4] University of MarylandBaltimore County,Department of Medicine, Division of Gerontology
[5] University of Maryland School of Medicine & Geriatric Research Education and Clinical Center,Department of Psychiatry and Behavioral Sciences
[6] Baltimore Veterans AffairsMedical Center,Department of Psychology
[7] Eastern Virginia Medical School,undefined
[8] Salisbury University,undefined
来源
International Journal of Behavioral Medicine | 2007年 / 14卷
关键词
silent ischemia; older adults; cardiovascular reactivity;
D O I
暂无
中图分类号
学科分类号
摘要
To determine if older, asymptomatic individuals with no prior history of coronary heart disease with exercise-induced silent myocardial ischemia (SI) during graded exercise treadmill testing exhibit exaggerated cardiovascular reactivity to anger provocation, we compared 42 SI participants and 95 controls. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) changes from baseline to three tasks & #x2014;anger recall, speech role-play, and mental arithmetic with harassment & #x2014;were assessed. Compared to controls, SI displayed greater HR responses for the speech role-play task only. The SI group was significantly older, had higher levels of fasting glucose and triglycerides, and had lower HDL-cholesterol. In multiple regression analyses, after controlling for these differences, SI was significantly associated with greater HR responses to the speech role-play. In sum, the SI group had significantly exaggerated HR responses to the speech role-play task, whereas SBP and DBP reactivity were comparable between groups. This suggests minimally enhanced cardiovascular reactivity among older SI patients that may nonetheless increase risk for cardiac events.
引用
收藏
页码:134 / 140
页数:6
相关论文
共 280 条
[1]  
Aronow W. S.(2002)Prevalence of and association between silent myocardial ischemia and new coronary events in older men and women with and without cardiovascular disease Journal of the American Geriatric Society 50 1075-1078
[2]  
Ahn C.(1996)Left ventricular, peripheral vascular, and neurohumoral responses to mental stress in normal middle-aged men and women. Reference group for the Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study Circulation 94 2768-2777
[3]  
Mecando A. D.(1990)Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia American Journal of Cardiology 65 93-98
[4]  
Epstein S.(1995)Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features Circulation 92 2102-2108
[5]  
Becker L. C.(1969)Exercise testing in the evaluation of patients with ischemic heart disease Progress in Cardiovascular Diseases 11 371-390
[6]  
Pepine C. J.(2003)Silent myocardial ischemia Circulation 108 1263-1277
[7]  
Bonsall R.(2000)Silent myocardial ischemia in the elderly Drugs and Aging 16 381-389
[8]  
Cohen J. D.(1990)Prevalence and prognostic significance of exercise-induced silentmyocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers Circulation 81 428-436
[9]  
Goldberg A. D.(2004)U.S. Preventive Services Task Force. Exercise tolerance testing to screen for coronary heart disease: A systematic review for the technical support for the U.S. Preventive Services Task Force Annals of Internal Medicine 140 W9-24
[10]  
Coghlan C.(1972)Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge Clinical Chemistry 18 499-502